Crossmark

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

Published Online: 2023-04-19

Authors

Gu, Chunyan

Wang, Yajun

Zhang, Lulin

Qiao, Li

Sun, Shanliang

Shao, Miaomiao

Tang, Xiaozhu

Ding, Pinggang

Tang, Chao

Cao, Yuhao

Zhou, Yanyan

Guo, Mengjie

Wei, Rongfang

Li, Nianguang

Xiao, Yibei

Duan, Jinao

Yang, Ye
License Information

Text and Data Mining valid from 2023-04-19

Version of Record valid from 2023-04-19
More Information

Article History

First Online: 19 April 2023

Document is current